Waypoint Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Waypoint Capital Advisors, LLC

  • $407 Million
  • Q3 2024

A detailed history of Waypoint Capital Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Waypoint Capital Advisors, LLC holds 4,006 shares of XBI stock, worth $456,724. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,006
Previous 4,006 -0.0%
Holding current value
$456,724
Previous $371,000 6.47%
% of portfolio
0.1%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$82.22 - $94.12 $411 - $470
5 Added 0.12%
4,006 $371,000
Q4 2023

Jan 22, 2024
BUY
$64.12 - $90.86 $64 - $90
1 Added 0.03%
4,001 $357,000
Q2 2022

Jul 18, 2022
BUY
$62.81 - $96.09 $251,240 - $384,360
4,000 New
4,000 $297,000

Others Institutions Holding XBI

# of Institutions
850
Shares Held
121M
Call Options Held
28.4M
Put Options Held
34.2M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Waypoint Capital Advisors, LLC Portfolio

Follow Waypoint Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email